1. Home
  2. AQST vs RITR Comparison

AQST vs RITR Comparison

Compare AQST & RITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • RITR
  • Stock Information
  • Founded
  • AQST 2004
  • RITR 2015
  • Country
  • AQST United States
  • RITR Hong Kong
  • Employees
  • AQST N/A
  • RITR N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • RITR
  • Sector
  • AQST Health Care
  • RITR
  • Exchange
  • AQST Nasdaq
  • RITR NYSE
  • Market Cap
  • AQST 272.9M
  • RITR 221.1M
  • IPO Year
  • AQST 2018
  • RITR 2024
  • Fundamental
  • Price
  • AQST $3.40
  • RITR $5.12
  • Analyst Decision
  • AQST Strong Buy
  • RITR
  • Analyst Count
  • AQST 6
  • RITR 0
  • Target Price
  • AQST $10.67
  • RITR N/A
  • AVG Volume (30 Days)
  • AQST 1.6M
  • RITR 1.0M
  • Earning Date
  • AQST 08-05-2025
  • RITR 02-15-2025
  • Dividend Yield
  • AQST N/A
  • RITR N/A
  • EPS Growth
  • AQST N/A
  • RITR N/A
  • EPS
  • AQST N/A
  • RITR 0.09
  • Revenue
  • AQST $54,228,000.00
  • RITR $47,948,887.00
  • Revenue This Year
  • AQST N/A
  • RITR N/A
  • Revenue Next Year
  • AQST $45.71
  • RITR N/A
  • P/E Ratio
  • AQST N/A
  • RITR $51.90
  • Revenue Growth
  • AQST 5.29
  • RITR 278.44
  • 52 Week Low
  • AQST $2.12
  • RITR $2.24
  • 52 Week High
  • AQST $5.80
  • RITR $8.75
  • Technical
  • Relative Strength Index (RSI)
  • AQST 58.21
  • RITR N/A
  • Support Level
  • AQST $3.13
  • RITR N/A
  • Resistance Level
  • AQST $3.33
  • RITR N/A
  • Average True Range (ATR)
  • AQST 0.21
  • RITR 0.00
  • MACD
  • AQST -0.03
  • RITR 0.00
  • Stochastic Oscillator
  • AQST 46.94
  • RITR 0.00

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About RITR REITAR LOGTECH HLDGS LTD

Reitar Logtech Holdings Ltd provide one-stop solutions for logistics property operations in property development and redevelopment projects. It consists of two segments: construction management and engineering design services; and asset management and professional consultancy services in Hong Kong. Key revenue is generated from construction management and engineering design services.

Share on Social Networks: